Oxford Immunotec Global PLC Total Revenue

Oxford Immunotec Global PLC posts a total revenue of $57M as of September 2020. That compares with $71M in the prior-year period — down 19.3% year over year. That is below the Healthcare sector average of $110B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Oxford Immunotec Global PLC's total revenue was $71M. The latest reading is $57M — a 19.3% year-over-year decrease (period ending September 2020). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a total revenue near $110B is typical. Oxford Immunotec Global PLC's $57M is lower that level. That is roughly 99.9% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Total Revenue is one piece of Oxford Immunotec Global PLC's financial statement story. At $57M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for OXFD's total revenue usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $110B), and (3) consistency with growth and profitability. This page covers the first two; Oxford Immunotec Global PLC's other metric pages and overview cover the third.